Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Companies

Results 1 - 1 out of 1 displayed.
 
Search filter:
  • Search for: Company
Sort direction:
Sort direction:
 |   |   | 
Headquarters
San Carlos, California, USA
Main sector:
  • Biotechnology - Therapeutics and Diagnostics
Subsector:
  • Vaccines
Indications:
  • Infectious and parasitic diseases / infectiology / parasitology
Employees:
  • Worldwide: 254
Products:
  • In development: 8
Description:
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a Phase 3-ready 24-valent, broad-spectrum, carrier-sparing PCV being developed for the prevention of IPD. VAX-31, the Company’s next-generation 31-valent PCV, is the broadest-spectrum PCV...

Already have a valid Biotechgate account? Login here »

Get access to Biotechgate

Download complete company profiles including product pipelines, financing rounds and management details.


to the top ↑